Indeed, UGCG mRNA expression and GlcCer levels are increased in the livers of mice with mechanistic target of rapamycin (mTOR)-activated HCC tumors, and UGCG inhibition reduced proliferation of hepatocytes, tumor burden, and markers of liver damage [37]. Here, MTOR is linked to hepatocellular carcinoma.